Intarcia Therapeutics, Inc.

Durect Corporation

Indivior UK Limited

Jazz Pharmaceuticals Ireland Limited

Alza Corporation

Andrew S. Luk

Guohua Chen

Gunjan H. Junnarkar

Gunjan H Junnarkar

Andrew S Luk

Catherine Manya Rohloff

Yuanpeng Zhang

Rom Ezer Eliaz

Eric William Weeks

Clark Patrick Allphin

Katayoun Zomorodi

Michael A Desjardin

John P Carr

Mark Eller

Cuiping Chen

Roman Skowronski

Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cto Cratio of less than 200 and a lag time less than 0.2.

Sustained release small molecule drug formulation

The present invention is related to methods for lowering peroxide levels in sucrose acetate isobutyrate formulations and to composition used in and formed by such methods.

Peroxide removal from drug delivery vehicle

An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cto Cratio less than 200 and lag time less than 0.2.

A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.

Methods of manufacturing viscous liquid pharmaceutical formulations

Particle formulations for use in pharmaceutical compositions

Composition and dosage form comprising a particle formulation and suspending vehicle

Composition and dosage form comprising an interferon particle formulation and suspending vehicle

Growing community of inventors

Palo Alto, CA, United States of America

Gunjan H Junnarkar